Recalls / Generics / Bupivacaine
Bupivacaine
1 FDA drug recall involving generic “Bupivacaine”.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2019-11-21 | Class II | EXPAREL, Bupivicaine Liposome Injectable Suspension, 1.3%, 266 mg/20 mL (13 mg/mL), Sterile, 20 mL vial, Rx on | Pacira Pharmaceuticals, Inc. |